☆ 4.7 Article

Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro)

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

From COVID-19 to clot: the involvement of the complement system

Mohamed A. Hendaus et al.

Summary: This paper discusses the role of the complement system and the associated pathogenesis in COVID-19. The complement system could potentially be a target for treatment and further investigation. Low molecular weight heparin may be life-saving for hospitalized COVID-19 patients. Agents that inhibit the complement cascade could play a crucial role in COVID-19 treatment.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Interaction of memantine with calf thymus DNA: anin-vitroandin-silicoapproach and cytotoxic effect on the cancerous cell lines

Faisal Ameen et al.

Summary: This study evaluated the interaction of memantine with DNA and its cytotoxicity on cancer cells. The results showed that memantine interacts with DNA primarily through groove binding. Molecular docking and density functional theory calculations confirmed the existence of this interaction. Molecular dynamics simulations further determined the stability of the interaction.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus

Akinwunmi O. Adeoye et al.

Summary: The study demonstrated the potential inhibitory effects of drugs like lopinavir and remdesivir on coronavirus, suggesting their repurposing as valuable treatments for preventing cellular entry and replication of the virus.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study

Sourav Das et al.

Summary: This study used a blind molecular docking approach to identify potential inhibitors of the SARS-COV-2 main protease, with rutin showing the highest inhibitor efficiency. All studied molecules were able to bind to the active site of the main protease and were surrounded by other active site residues. Further wet-lab experimentation and clinical trials are needed for validation.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Peptide-like and small-molecule inhibitors against Covid-19

Suyash Pant et al.

Summary: The study identified potential protease inhibitors against SARS-CoV-2 using computational approaches, screening compounds from various databases and conducting docking and molecular dynamics simulations to find promising drugs.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach

Lovika Mittal et al.

Summary: The COVID-19 pandemic has driven the search for rapid therapeutic strategies, with in-silico techniques being used to repurpose existing drugs and molecules to identify potential candidates. This approach has led to the discovery of several promising drug candidates, including anti-protease molecules, that show significant potential as inhibitors of the main protease of the novel coronavirus.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin

Anwarul Hasan et al.

Summary: This review discusses the interactions between the novel coronavirus SARS-CoV-2 and human cells, highlighting the role of important receptors like ACE-2 and furin in the virus invasion. It explores the potential inhibitory effects of compounds on the virus, as well as future prospects for drug development.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets

Saurabh K. Sinha et al.

Summary: The study investigated the potential of Saikosaponins in inhibiting SARS-CoV-2 by conducting computational molecular docking simulations. Saikosaponins U and V showed promising affinity towards key proteins involved in viral replication and host cell entry, suggesting them as potential candidates for further research and development.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants

Gideon A. Gyebi et al.

Summary: The study screened alkaloids and terpenoids from African plants as potential inhibitors of coronavirus 3CL(pro). Over half of the top twenty compounds showed favorable interactions with coronaviruses 3CL(pro) and higher binding affinities than lopinavir and ritonavir. Seven promising compounds were identified, including four non-toxic, druggable plant-derived alkaloids and terpenoids that bind to the receptor-binding site and catalytic dyad of SARS-CoV-2 3CL(pro). Further experimental analyses are needed for developing these compounds as natural anti-COVID-19 therapeutic agents.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Letter Biochemistry & Molecular Biology

Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: anin silicobased approach

Saurov Mahanta et al.

Summary: The study identified Viomycin as a potential inhibitor of the Main Protease of SARS-CoV-2, showing higher -CDocker energy and forming more hydrogen bonds with the protein compared to drugs like Ritonavir and Lopinavir currently under clinical trial. Molecular dynamics simulation suggested that Viomycin had strong binding with the Main Protease, indicating its potential as a treatment option for the pandemic.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2

Satyajit Beura et al.

Summary: This study investigates the interactions of Chloroquine and its derivatives with SARS-CoV-2 using computational approaches like pharmacophore model, molecular docking, MM_GBSA study, and ADME property analysis. The study explores the structural properties of the compounds, ligand-receptor interactions, binding free energy of the protein-ligand complex, and pharmacological properties of the compounds to identify the best molecule for inhibiting SARS-CoV-2.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening

Osmair Vital de Oliveira et al.

Summary: In this study, molecular modeling techniques were used to identify potential drug candidates against SARS-CoV-2 by observing conformational changes and antigen exposure through molecular dynamics simulation. A total of 24 potential candidates, including traditional herbal isolates and approved drugs, were selected from a large drug database based on binding energy calculations.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Targeting the protein-protein interface pocket of Aurora-A-TPX2 complex: rational drug design and validation

Vijay Kumar Bhardwaj et al.

Summary: Aurora-A is a novel therapeutic target associated with gene amplification or over-expression in cancers. By predicting a binding pocket, potential bioactive molecules were identified to restore lost interaction between mutant Aurora-A and TPX2, showing promise as potent drugs to tackle abnormal expression caused by somatic mutations.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

A computational prediction of SARS-CoV-2 structural protein inhibitors fromAzadirachta indica(Neem)

Subhomoi Borkotoky et al.

Summary: Computational screening of compounds from an Indian medicinal plant identified potential inhibitors for SARS-CoV-2 M and E proteins, showing promise for effective antiviral drug discovery.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Molecular docking, simulation and MM-PBSA studies ofnigella sativacompounds: a computational quest to identify potential natural antiviral for COVID-19 treatment

Sajjad Ahmad et al.

Summary: Black seed, traditionally used as a medicinal plant, has shown potential therapeutic effects against various diseases. Dithymoquinone (DTQ), a compound found in black seed, demonstrated high binding affinity to disrupt viral-host interactions in the study and could potentially be developed as a natural antiviral against COVID-19.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19

Anshuman Chandra et al.

Summary: The study identified two drugs, Glisoxepide and Idarubicin, as strong binders of EndoU in SARS-CoV-2, forming attractive interactions with catalytically essential amino acid residues in the active site of the enzyme. Molecular dynamics simulations confirmed stable conformation dynamics upon drug binding, with calculated binding free energies indicating their potential therapeutic efficacy for COVID-19.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations

I. Aanouz et al.

Summary: The new coronavirus, known as SARS-CoV-2, first appeared in Wuhan, China. Research is being done on natural herbal remedies, with three molecules showing potential as inhibitors against the coronavirus.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria

Imane Abdelli et al.

Summary: The study focuses on screening an alternative drug to block ACE2 activity as a receptor for SARS-CoV-2, with Isothymol from Ammoides verticillata showing the best docking scores. This study suggests that Isothymol and other natural compounds could be potential inhibitors for the ACE2 receptor of SARS-CoV-2.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Letter Biochemistry & Molecular Biology

Synergistic effect of vitamin D and remdesivir can fight COVID-19

Aditya Arya et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment

Subramanian Boopathi et al.

Summary: The world has faced several infectious disease outbreaks in the past two decades, with the novel coronavirus 2019 having a significant global impact. With millions infected and thousands dead, only a few Asian countries have managed to control the disease, but a second wave of infections is expected. Predicting inhibitors and targets for COVID-19 is urgent, with computer-aided drug design playing a crucial role in this process.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2

Rajib Islam et al.

Summary: The study identified potential inhibitors against SARS-CoV-2 main protease from 40 antiviral phytochemicals via molecular docking and molecular dynamics simulations. A QSAR model was established to predict favorable binding energy, and the selected candidates were found to be safer inhibitors through ADMET analysis. The computational and statistical analysis supported the potential of these phytochemicals as antiviral agents against SARS-CoV-2.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease

Rakesh S. Joshi et al.

Summary: The study indicates structural divergence of the main protease (M-Pro) within the Coronaviridae family but with conserved structural features. Researchers identified several natural molecules, such as delta-viniferin, myricitrin, that strongly bind to SARS-CoV-2 M-Pro and other potential targets. This approach of multi-target-directed ligand identification may provide new avenues for drug discovery against SARS-CoV-2 infection.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication

Naun Lobo-Galo et al.

Summary: Given the current lack of specific antiviral treatment or vaccine for COVID-19, the search for drugs that can potentially inhibit essential viral enzymes is urgent. Through in silico testing, disulfiram and its metabolites are identified as potential antiviral drugs, with a proposed mechanism for their action.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Letter Biochemistry & Molecular Biology

Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19

Nisha Muralidharan et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2

Khattab Al-Khafaji et al.

Summary: The study evaluated FDA approved drugs for their effectiveness in forming a covalent bond with SARS-CoV-2 main protease, with the aim of identifying potential therapeutics for the treatment of COVID-19. The results showed promising binding energies for certain drugs, suggesting their potential use in the treatment of SARS-CoV-2.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Stilbene-based natural compounds as promising drug candidates against COVID-19

Hussain Mustatab Wahedi et al.

Summary: The study suggests that stilbenoid compounds, especially resveratrol, could be promising candidates for anti-COVID-19 drugs by disrupting the structure of the viral protein.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target

Umesh et al.

Summary: Chemical compounds from Indian spices, such as Carnosol, Arjunglucoside-I, and Rosmanol, have shown potential as inhibitors of SARS-CoV-2 main protease in molecular docking experiments. These compounds exhibit strong and stable binding affinity with the active site of SARS-CoV-2 Mpro, suggesting they could be promising candidates for anti-viral drugs against nCoV pending further validation through clinical trials.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach

Sukanth Kumar Enmozhi et al.

Summary: The SARS-CoV-2 virus has caused a global pandemic with over 1.2 million confirmed cases and nearly 65,000 deaths, leading to a search for effective treatments. Clinical trials are being conducted on antiviral drugs, but the lack of approved treatments highlights the need for novel compounds. Andrographolide from Andrographis paniculata shows promise as an inhibitor for SARS-CoV-2 main protease, with in silico studies suggesting good solubility, pharmacodynamics properties, and target accuracy.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)

Phulen Sarma et al.

Summary: This study targeted the RNA-binding N terminal domain of the N protein of coronavirus to identify possible inhibitors of RNA binding. Theophylline and pyrimidone derivatives were identified as potential inhibitors, opening up new avenues for in vitro validations of their RNA binding inhibition capabilities.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease

Chinmayee Choudhury

Summary: This study designed novel molecules targeting the main protease of SARS-CoV-2, which is crucial for viral replication, using computational methods. These molecules showed promising binding affinities and interactions with the virus, making them potential starting points for drug discovery against COVID-19.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms

Mark Tristan J. Quimque et al.

Summary: Through bioinformatics and computational modeling, ninety seven antiviral secondary metabolites from fungi were found to have high binding affinities on five SARS-CoV2 enzymes. Among them, Quinadoline B (19) showed favorable ADMET values and high gastrointestinal absorptive probability but poor blood-brain barrier crossing capacities.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Antiviral effects of probiotic metabolites on COVID-19

Firoz Anwar et al.

Summary: SARS coronavirus (COVID-19) poses a significant health challenge in the 21st century. This study focuses on using probiotics to block virus entry into cells and potentially treat COVID-19.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Homology modeling andin silicodesign of novel and potential dual-acting inhibitors of human histone deacetylases HDAC5 and HDAC9 isozymes

Ammar D. Elmezayen et al.

Summary: In this study, protein models of HDAC5 and HDAC9 were constructed using homology modeling approach based on a template. The selected models were validated and subjected to molecular dynamic simulations, which indicated their stability and reliability for designing novel inhibitors targeting HDAC5 and HDAC9. The results obtained in this study could be valuable for future drug design efforts against these enzymes.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Exploring the energetic basis of binding of currently used drugs against HIV-1 subtype CRF01_AE protease via molecular dynamics simulations

Md Fulbabu Sk et al.

Summary: The study reveals that tipranavir is the most potent inhibitor against PR(CRF) and the other three PIs display similar binding affinity. The energetic penalty due to desolvation of polar groups always disfavors the association between PR(CRF) and PIs, with tipranavir showing the least contribution. Van der Waals forces primarily control the binding of inhibitors with PR(CRF).

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Calcium ion binding to calmodulin: binding free energy calculation using the molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) method by incorporating implicit polarization

Abdul Basit et al.

Summary: Binding of calcium ion to calcium-binding proteins triggers various biological processes, but calculating the binding affinity remains challenging. Implicit polarization method improves agreement between calculated and experimental results, indicating further improvement is necessary for quantitative match.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Investigating Cryptic Binding Sites by Molecular Dynamics Simulations

Antonija Kuzmanic et al.

ACCOUNTS OF CHEMICAL RESEARCH (2020)

Add to Collection

Article Medicine, Research & Experimental

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

Abdo A. Elfiky

LIFE SCIENCES (2020)

Add to Collection

Editorial Material Biotechnology & Applied Microbiology

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

Guangdi Li et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Add to Collection

Article Biochemical Research Methods

Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus

Sen Liu et al.

BIOINFORMATICS (2020)

Add to Collection

Article Medicine, General & Internal

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model

Hua-Hao Fan et al.

CHINESE MEDICAL JOURNAL (2020)

Add to Collection

Article Chemistry, Medicinal

COVID-19 treatment by repurposing drugs until the vaccine is in sight

Mrudula Phadke et al.

DRUG DEVELOPMENT RESEARCH (2020)

Add to Collection

Article Infectious Diseases

Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe

Paola Stefanelli et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Infectious Diseases

Drug repositioning is an alternative for the treatment of coronavirus COVID-19

Marissa B. Serafin et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Add to Collection

Article Infectious Diseases

Combating devastating COVID-19 by drug repurposing

Ashish Yashwantrao Pawar

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Add to Collection

Article Infectious Diseases

Teicoplanin: an alternative drug for the treatment of COVID-19?

Sophie Alexandra Baron et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

COVID-19 Drug Discovery Using Intensive Approaches

Ayumu Asai et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Biochemistry & Molecular Biology

A Review of SARS-CoV-2 and the Ongoing Clinical Trials

Yung-Fang Tu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Multidisciplinary Sciences

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

Linlin Zhang et al.

SCIENCE (2020)

Add to Collection

Article Virology

The establishment of reference sequence for SARS-CoV-2 and variation analysis

Changtai Wang et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Article Infectious Diseases

Supporting pandemic response using genomics and bioinformatics: A case study on the emergent SARS-CoV-2 outbreak

Denis C. Bauer et al.

TRANSBOUNDARY AND EMERGING DISEASES (2020)

Add to Collection

Letter Biology

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

Jianjun Gao et al.

BIOSCIENCE TRENDS (2020)

Add to Collection

Article Public, Environmental & Occupational Health

A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease

Donald C. Hall et al.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)

Add to Collection

Correction Multidisciplinary Sciences

A new coronavirus associated with human respiratory disease in China (vol 579, pg 265, 2020)

Fan Wu et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

David E. Gordon et al.

NATURE (2020)

Add to Collection

Letter Biochemistry & Molecular Biology

The proximal origin of SARS-CoV-2

Kristian G. Andersen et al.

NATURE MEDICINE (2020)

Add to Collection

Review Microbiology

Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)

Muhammad Shahid Nadeem et al.

PATHOGENS (2020)

Add to Collection

Article Pharmacology & Pharmacy

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

Leon Caly et al.

ANTIVIRAL RESEARCH (2020)

Add to Collection

Letter Infectious Diseases

Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species

Chun Li et al.

INFECTION GENETICS AND EVOLUTION (2020)

Add to Collection

Article Medicine, Research & Experimental

Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study

Abdo A. Elfiky

LIFE SCIENCES (2020)

Add to Collection

Article Medicine, Research & Experimental

In silico studies on therapeutic agents for COVID-19: Drug repurposing approach

Bhumi Shah et al.

LIFE SCIENCES (2020)

Add to Collection

Article Medicine, Research & Experimental

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease

Mahmoud Kandeel et al.

LIFE SCIENCES (2020)

Add to Collection

Review Pharmacology & Pharmacy

Drug targets for corona virus: A systematic review

Manisha Prajapat et al.

INDIAN JOURNAL OF PHARMACOLOGY (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Clinical trials on drug repositioning for COVID-19 treatment

Sandro G. Viveiros Rosa et al.

REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2020)

Add to Collection

Article Biochemical Research Methods

Large-scale prediction of binding affinity in protein-small ligand complexes: the PRODIGY-LIG web server

Anna Vangone et al.

BIOINFORMATICS (2019)

Add to Collection

Article Chemistry, Multidisciplinary

Detecting early stage structural changes in wild type, pathogenic and non-pathogenic prion variants using Markov state model

Vinod Jani et al.

RSC ADVANCES (2019)

Add to Collection

Editorial Material Immunology

Uncommon presentation of a less common tumour

Keshavamurthy Vinay et al.

INDIAN JOURNAL OF MEDICAL RESEARCH (2016)

Add to Collection

Article Chemistry, Physical

Markov state models of protein misfolding

Anshul Sirur et al.

JOURNAL OF CHEMICAL PHYSICS (2016)

Add to Collection

Article Chemistry, Physical

PyEMMA 2: A Software Package for Estimation, Validation, and Analysis of Markov Models

Martin K. Scherer et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)

Add to Collection

Article Chemistry, Multidisciplinary

DOCK 6: Impact of New Features and Current Docking Performance

William J. Allen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2015)

Add to Collection

Article Biochemistry & Molecular Biology

PLIP: fully automated protein-ligand interaction profiler

Sebastian Salentin et al.

NUCLEIC ACIDS RESEARCH (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Markov state models of biomolecular conformational dynamics

John D. Chodera et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

SWEETLEAD: an In Silico Database of Approved Drugs, Regulated Chemicals, and Herbal Isolates for Computer-Aided Drug Discovery

Paul A. Novick et al.

PLOS ONE (2013)

Add to Collection

Article Chemistry, Medicinal

LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery

Roman A. Laskowski et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)

Add to Collection

Article Chemistry, Physical

Markov models of molecular kinetics: Generation and validation

Jan-Hendrik Prinz et al.

JOURNAL OF CHEMICAL PHYSICS (2011)

Add to Collection

Article Chemistry, Physical

Automatic discovery of metastable states for the construction of Markov models of macromolecular conformational dynamics

John D. Chodera et al.

JOURNAL OF CHEMICAL PHYSICS (2007)

Add to Collection

Article Infectious Diseases

Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase

D Xu et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)

Add to Collection

Article Chemistry, Multidisciplinary

UCSF chimera - A visualization system for exploratory research and analysis

EF Pettersen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.